Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label rituximab in resistant rheumatoid arthritis
2005-000674-43Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Oct 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rituximab in rheumatoid arthritis (RA), sponsored by University of Leeds. Primary endpoint: ACR50 response at Week 24. Started Oct 2005; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-000674-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000674-43.